157 related articles for article (PubMed ID: 17766106)
1. Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.
Kawai M; Ando K; Matsumoto Y; Sakurada I; Hirota M; Nakamura H; Ohta A; Sudo M; Hattori K; Takashima T; Hizue M; Watanabe S; Fujita I; Mizutani M; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5558-62. PubMed ID: 17766106
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047
[TBL] [Abstract][Full Text] [Related]
3. Solid-state characterization of an NR2B selective N-methyl d-aspartate (NMDA) antagonist polymorphs.
Kojima T; Sato M; Omura A; Kawai M; Sakai M; Matsuoka Y; Murata Y; Hattori K; Sakemi S; Bordner J; Samardjiev I; Mano T
Int J Pharm; 2008 May; 355(1-2):337-40. PubMed ID: 18242021
[TBL] [Abstract][Full Text] [Related]
4. Synergy between a NR2B receptor antagonist DHQ and 3-methyl-gabapentin in mice with neuropathic pain.
Imai A; Hizue M; Toide K
Eur J Pharmacol; 2008 Jul; 588(2-3):244-7. PubMed ID: 18511033
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a series of γ-amino alcohols comprising an N-methyl isoindoline moiety and their evaluation as NMDA receptor antagonists.
Müller A; Höfner G; Renukappa-Gutke T; Parsons CG; Wanner KT
Bioorg Med Chem Lett; 2011 Oct; 21(19):5795-9. PubMed ID: 21875803
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.
McIntyre CJ; McCauley JA; Bednar B; Bednar RA; Butcher JW; Claremon DA; Cunningham ME; Freidinger RM; Gaul SL; Homnick CF; Koblan KS; Mosser SD; Romano JJ; Liverton NJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):5132-5. PubMed ID: 19648007
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
[TBL] [Abstract][Full Text] [Related]
8. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Gogas KR
Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
Liverton NJ; Bednar RA; Bednar B; Butcher JW; Claiborne CF; Claremon DA; Cunningham M; DiLella AG; Gaul SL; Libby BE; Lyle EA; Lynch JJ; McCauley JA; Mosser SD; Nguyen KT; Stump GL; Sun H; Wang H; Yergey J; Koblan KS
J Med Chem; 2007 Feb; 50(4):807-19. PubMed ID: 17249648
[TBL] [Abstract][Full Text] [Related]
10. Reduction of hERG inhibitory activity in the 4-piperidinyl urea series of H3 antagonists.
Berlin M; Lee YJ; Boyce CW; Wang Y; Aslanian R; McCormick KD; Sorota S; Williams SM; West RE; Korfmacher W
Bioorg Med Chem Lett; 2010 Apr; 20(7):2359-64. PubMed ID: 20188550
[TBL] [Abstract][Full Text] [Related]
11. Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors.
Roger G; Dollé F; De Bruin B; Liu X; Besret L; Bramoullé Y; Coulon C; Ottaviani M; Bottlaender M; Valette H; Kassiou M
Bioorg Med Chem; 2004 Jun; 12(12):3229-37. PubMed ID: 15158791
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.
Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
ChemMedChem; 2010 May; 5(5):687-95. PubMed ID: 20340125
[TBL] [Abstract][Full Text] [Related]
13. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
Bioorg Med Chem; 2010 Nov; 18(22):8005-15. PubMed ID: 20965739
[TBL] [Abstract][Full Text] [Related]
14. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
15. NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
McCauley JA; Theberge CR; Romano JJ; Billings SB; Anderson KD; Claremon DA; Freidinger RM; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Xia M; Cunningham ME; Bednar B; Stump GL; Lynch JJ; Macaulay A; Wafford KA; Koblan KS; Liverton NJ
J Med Chem; 2004 Apr; 47(8):2089-96. PubMed ID: 15056006
[TBL] [Abstract][Full Text] [Related]
16. Oxamides as novel NR2B selective NMDA receptor antagonists.
Barta-Szalai G; Borza I; Bozó E; Kiss C; Agai B; Proszenyák A; Keseru GM; Gere A; Kolok S; Galgóczy K; Horváth C; Farkas S; Domány G
Bioorg Med Chem Lett; 2004 Aug; 14(15):3953-6. PubMed ID: 15225705
[TBL] [Abstract][Full Text] [Related]
17. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
Schotanus SM; Chergui K
Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
[TBL] [Abstract][Full Text] [Related]
18. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
[TBL] [Abstract][Full Text] [Related]
19. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
[TBL] [Abstract][Full Text] [Related]
20. Isolations of N-methyl-D-aspartic acid-type glutamate receptor ligands from Micronesian sponges.
Sakai R; Matsubara H; Shimamoto K; Jimbo M; Kamiya H; Namikoshi M
J Nat Prod; 2003 Jun; 66(6):784-7. PubMed ID: 12828462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
